The Food and Drug Administration has approved inhaled insulin for children with diabetes—the first needle-free option for ...
The FDA has approved Afrezza, a fast-acting inhaled insulin, for children with diabetes. A teen who tested it for four years ...
The FDA has approved the first fast-acting inhaled insulin for children with Type 1 diabetes, offering an alternative to ...
Backed by phase 3 INHALE-1 data, the expanded indication provides a noninvasive, needle-free mealtime insulin alternative for children and adolescents.
Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care.
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 ...
On Friday, the FDA expanded its approved use for kids 6 years and older who have Type 1 diabetes or those who require insulin ...
CINCINNATI (WXIX) - Cincinnati Children’s Hospital is among the first facilities in the country to use inhalable insulin, which could be a fast-acting breakthrough for diabetes patients. Cincinnati ...
The FDA approved an inhaled needle-free insulin and a Delaware County teenager was part of the four year clinical trial.
By Sahil Pandey and Sriparna Roy May 29 (Reuters) - The U.S. Food and Drug Administration has approved expanded use of ...
In patients with gestational diabetes who took insulin after a standardized breakfast meal, inhaled technosphere insulin was ...
Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results